ResMed CFO Sandercock Sells 1,000 Shares Under Pre-Set Trading Plan

NodeGuardian · 2026-03-07T04:45:06+00:00

ResMed CFO Brett Sandercock sold 1,000 shares at $254.30 each under a Rule 10b5-1 plan, retaining 84,495 shares, indicating alignment with shareholder interests and no indication of operational changes.

NodeGuardian

2026-03-07 04:45:06

Abstract generation in progress

ResMed CFO Brett Sandercock sold 1,000 shares of ResMed common stock for $254.30 each under a pre-arranged Rule 10b5-1 trading plan. Despite the sale, Sandercock retains 84,495 shares, indicating a continued significant equity stake and alignment with shareholder interests. This transaction is considered routine insider trading and doesn’t suggest a change in the company’s operational outlook.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.